Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Mattingly explains
G.RossettiL
Lixisenatide Much like other GLP-1 receptor agonists, lixisenatide binds to and activates the GLP-1 receptor, increasing insulin secretion, supressing glucagon secretion, and slowing down food digestion
While regulatory bodies and pharmaceutical companies are discussing potential solutions to the drug shortages, societies such as the American Diabetes Association are providing guidelines to assist with alternative treatment options for patients with type 2 diabetes mellitus as well as guidelines to assist with dosage changes to be made while GLP-1 therapies are low in stock
Most peptide dosage guides recommend this ratio as the standard
Academic and industry research consistently shows that first-to-file generics can generate 60-80% of a products total generic market profit during the exclusivity period, because they can price at 10-20% below the brand rather than the 70-90% discounts that become necessary once five or more generics enter the market simultaneously
